[A study on the evaluation standards of osteoporosis in Korea]
Ahn J, Hyun MK, Kim Y, Suh HS, Park S, Park J, Sung YK, Lee EK
Record ID 32014000421
Authors' recomendations: The budget impact of the osteoporosis coverage extension plan was suggested to be 147 billion Korean won in the 2009 plan and 133.3 billion Korean won in the 2010 plan (the coverage will be extended to the lowest T-score less than -2.5 and one year coverage (scenario 2)) After adjusting for significant factors (age, sex, region, marital status, number of family members, and monthly average income of the family), the maximum annual WTPs increased to 24,000 Korean won per 10% rise of the vertebral fracture risk and increased to 28,800 Korean won per 10% rise in the hip fracture risk. To build an osteoporotic fracture prediction model, logistic regression analyses were performed for each gender and the two fracture groups (major osteoporotic fractures and all osteoporotic fractures). For females, the lowest T-score, age, and weight were significant factors that predicted osteoporotic fractures for both groups of fractures while the lowest T-score and age were only significant factors predicting osteoporotic fractures for both groups of fractures in males.
Project Status: Completed
Year Published: 2011
URL for published report: http://www.neca.re.kr/center/researcher/report_view.jsp?boardNo=GA&seq=16&q=626f6172644e6f3d4741
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: South Korea
- Reference Values
Organisation Name: National Evidence-based healthcare Collaborating Agency
Contact Address: National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: National Evidence-based Healthcare Collaborating Agency (NECA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.